These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2563217)

  • 1. Effects of somatostatin and oral potassium administration on terbutaline-induced hypokalemia.
    Schnack C; Podolsky A; Watzke H; Schernthaner G; Burghuber OC
    Am Rev Respir Dis; 1989 Jan; 139(1):176-80. PubMed ID: 2563217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses.
    Clifton GD; Hunt BA; Patel RC; Burki NK
    Am Rev Respir Dis; 1990 Mar; 141(3):575-9. PubMed ID: 2178522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritodrine- and terbutaline-induced hypokalemia in preterm labor: mechanisms and consequences.
    Braden GL; von Oeyen PT; Germain MJ; Watson DJ; Haag BL
    Kidney Int; 1997 Jun; 51(6):1867-75. PubMed ID: 9186877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of subcutaneously administered terbutaline on serum potassium in asymptomatic adult asthmatics.
    Küng M; White JR; Burki NK
    Am Rev Respir Dis; 1984 Feb; 129(2):329-32. PubMed ID: 6364906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downgrading of biochemical and cardiovascular responses to an intravenous infusion of terbutaline following chronic treatment with oral terbutaline.
    Smith SR; Kendall MJ
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):1-3. PubMed ID: 3957482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration and side-effects of terbutaline.
    Bengtsson B
    Eur J Respir Dis Suppl; 1984; 134():231-5. PubMed ID: 6373350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of the adverse effects of intravenous terbutaline by oral theophylline.
    Smith SR; Kendall MJ
    Br J Clin Pharmacol; 1986 Apr; 21(4):451-3. PubMed ID: 3707814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum potassium levels during and after terbutaline.
    Hurlbert BJ; Edelman JD; David K
    Anesth Analg; 1981 Oct; 60(10):723-5. PubMed ID: 7197475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypokalemia associated with terbutaline administration in obstetrical patients.
    Moravec MA; Hurlbert BJ
    Anesth Analg; 1980 Dec; 59(12):917-20. PubMed ID: 6108735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion induced by glucose and by stimulation of beta 2 -adrenoceptors in the rat. Different sensitivity to somatostatin.
    Ahrén B; Järhult J; Lundquist I
    Acta Physiol Scand; 1981 Aug; 112(4):421-6. PubMed ID: 6119001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-adrenoceptor induced increase of plasma insulin levels in man: evidence of direct and indirect B-cell stimulation and liver effects.
    Ahrén B; Scherstén B
    Diabetes Res; 1986 Nov; 3(9):443-5. PubMed ID: 3030608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-2-adrenoceptor-mediated hypokalemia and its abolishment by oxprenolol.
    Jonkers R; Van Boxtel CJ; Oosterhuis B
    Clin Pharmacol Ther; 1987 Dec; 42(6):627-33. PubMed ID: 2826064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against β adrenoceptor agonist reduction of plasma potassium in severe but not in moderate hypokalemia.
    Tran CT; Kjeldsen K
    Fundam Clin Pharmacol; 2011 Aug; 25(4):452-61. PubMed ID: 21401714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of enalapril and spironolactone on terbutaline-induced hypokalemia.
    Rahman AR; McDevitt DG; Struthers AD; Lipworth BJ
    Chest; 1992 Jul; 102(1):91-5. PubMed ID: 1623802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
    Deenstra M; Haalboom JR; Struyvenberg A
    Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the metabolic effects of terbutaline in beta2-adrenergic receptor diplotypes.
    Lima JJ; Matsushima N; Kissoon N; Wang J; Sylvester JE; Jusko WJ
    Clin Pharmacol Ther; 2004 Jul; 76(1):27-37. PubMed ID: 15229461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute asthma--plasma levels and effect of terbutaline i.v. injection.
    Boe J; Carlsson LG; Hetta L; Karlson B; Ljungholm K
    Eur J Respir Dis; 1985 Oct; 67(4):261-8. PubMed ID: 4076365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The hypokalemic effect of adrenaline is increased by nitrendipine in normal man].
    Mimran A; Ribstein J
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):835-8. PubMed ID: 3116982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological doses of glucagon cause a transient increase of the hepatic vein potassium concentration in man.
    Massara F; Cagliero E; Maccario M; Orzan F; Carini G
    Miner Electrolyte Metab; 1986; 12(2):142-6. PubMed ID: 2870423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.